Skip to content Skip to sidebar Skip to footer

Newsletter

Ujjwal Maheshwari

Ujjwal Maheshwari is a Sydney-based financial writer at Stocks Down Under, where he has covered ASX and forex markets for over three years. He specialises in breaking down complex market developments into clear, accessible analysis for everyday investors.

Bachelor of Commerce (Finance), University of New South Wales (UNSW)

654 articles published

Mining Stocks

Elevra Lithium (ASX:ELV) Banks US$71m From Huayou as Pure North American Pivot Completes

Elevra Lithium Rises After US$71m Huayou Deal Elevra Lithium (ASX:ELV) is walking away from Africa. The company has agreed to sell its interest in Ghana's Ewoyaa Lithium Project to China's Zhejiang Huayou Cobalt for around US$71 million (before fees and taxes), or approximately A$98 million, in cash. Shares finished the day 1.7% higher at A$13.74…

ByUjjwal MaheshwariMay 12, 20260Comments

Consumer

Inghams (ASX:ING) Becomes Confession Season’s Surprise Winner with 7.4% Rally

Inghams Rallies 7.4% After Holding Guidance Inghams (ASX:ING) jumped 7.4% on Monday to close at A$1.82. That might not sound huge, but for a stock that recently fell to an all-time low of around A$1.78 in March and is down about 55% over the past year, it was a big day. The rally came after…

ByUjjwal MaheshwariMay 12, 20260Comments

Market news

oOh!media (ASX:OML) Jumps 7% as I Squared Tops PEP With A$770m Bid, Board Says Still Not Enough

oOh!media Jumps as A$770m Bid War Heats Up oOh!media (ASX:OML) jumped around 7% on Monday after I Squared Capital lobbed a fresh takeover offer at A$1.45 per share. That values the outdoor advertising group at roughly A$770 million and tops the A$1.40 per share offer from Pacific Equity Partners (PEP) made on 29 April. The…

ByUjjwal MaheshwariMay 11, 20260Comments

Industrials

Shares in Dyno Nobel (ASX:DNL) Jump 8% Today as Explosives EBIT Surges 39%

Dyno Nobel Shares Rise on 39% EBIT Jump Dyno Nobel (ASX:DNL) jumped as much as 10.8% to a fresh 52-week high of A$3.68 today before settling at A$3.56, up 7.23%. The rally came after a strong first-half result that showed sharp profit growth across the explosives business. After two years of restructuring and selling off…

ByUjjwal MaheshwariMay 11, 20260Comments

Financials

QBE Insurance (ASX:QBE) Falls 1.5% Despite 11% Q1 Premium Growth: What Worried the Market

QBE Insurance Shares Slip Despite Strong Q1 Premium Growth QBE Insurance (ASX:QBE) gave a quarterly update on Friday that looked good on paper. Total premium income grew 11% year-on-year to US$9.2bn, full-year guidance was reaffirmed, disaster claims remained within budget, and exposure to the Middle East conflict was small at around US$60m. The market still…

ByUjjwal MaheshwariMay 11, 20260Comments

Defence Stocks

ASX Defence Stocks Rally as Iran Ceasefire Wobbles: 4 Names Investors Should Watch on Monday

ASX Defence Stocks Rally as Iran Ceasefire Wobbles US-Iran tensions flared again on Friday after the US Central Command intercepted Iranian attacks on Navy ships in the Strait of Hormuz. The UAE's air defences also engaged incoming missiles and drones soon after. The ASX 200 closed down 1.74%, oil pushed above US$101 a barrel, and…

ByUjjwal MaheshwariMay 11, 20260Comments

Market news

Federal Budget 2026: Should You Sell ASX Shares Before Tuesday Night’s CGT Changes?

Federal Budget 2026 CGT Changes for ASX Investors The Federal Budget drops at 7:30 pm on Tuesday, 12 May. And one question is on every long-term ASX investor's mind this weekend: should you sell some shares before Treasurer Jim Chalmers stands up to speak? The 50% capital gains tax discount has been part of the…

ByUjjwal MaheshwariMay 11, 20260Comments

Healthcare Stocks

Amplia (ASX:ATX) Adds Ovarian Trial with ANZGOG After Narmafotinib Hits 35% Pancreatic Response Rate

Amplia Adds Ovarian Trial After Pancreatic Success Amplia Therapeutics (ASX:ATX) has opened a new chapter in its drug story. On 8 May, the small-cap biotech announced a partnership with the Australia New Zealand Gynaecological Oncology Group (ANZGOG) to test its lead drug, narmafotinib, in ovarian cancer. The new study, called PRROSE, will treat patients with…

ByUjjwal MaheshwariMay 11, 20260Comments

Property Real Estate

REA Group (ASX:REA) Defies ASX Sell-Off With 16% Profit Surge: Is the Rebound Finally Here?

REA Group Rebounds as Margins and Growth Improve REA Group (ASX:REA) released its Q3 FY26 update on Thursday, and the result clearly resonated with investors. On Friday, while the ASX 200 plunged 1.5% on renewed Middle East tensions, REA Group defied the sell-off to gain 1.38%, closing at A$176.89. The numbers behind the result were…

ByUjjwal MaheshwariMay 9, 20260Comments

Lithium Stocks

5 ASX Lithium Stocks Set to Rally After Albemarle’s 672% Profit Boom

Albemarle (NYSE: ALB), the world's biggest lithium producer, just delivered an eye-popping result. Profit jumped 672% to US$319 million in Q1 2026, blowing past expectations. The lithium business alone saw earnings nearly triple, and shares rallied sharply on the news. For ASX lithium investors, this matters far more than one strong US quarter. We believe it's…

ByUjjwal MaheshwariMay 9, 20260Comments

the Kick-ass Multipurpose WordPress Theme

Ujjwal Maheshwari

Elevra Lithium (ASX:ELV) Banks US$71m From Huayou as Pure North American Pivot Completes

Inghams (ASX:ING) Becomes Confession Season’s Surprise Winner with 7.4% Rally

oOh!media (ASX:OML) Jumps 7% as I Squared Tops PEP With A$770m Bid, Board Says Still Not Enough

Shares in Dyno Nobel (ASX:DNL) Jump 8% Today as Explosives EBIT Surges 39%

QBE Insurance (ASX:QBE) Falls 1.5% Despite 11% Q1 Premium Growth: What Worried the Market

ASX Defence Stocks Rally as Iran Ceasefire Wobbles: 4 Names Investors Should Watch on Monday

Federal Budget 2026: Should You Sell ASX Shares Before Tuesday Night’s CGT Changes?

Amplia (ASX:ATX) Adds Ovarian Trial with ANZGOG After Narmafotinib Hits 35% Pancreatic Response Rate

REA Group (ASX:REA) Defies ASX Sell-Off With 16% Profit Surge: Is the Rebound Finally Here?

5 ASX Lithium Stocks Set to Rally After Albemarle’s 672% Profit Boom

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Ujjwal Maheshwari

Stocks in Spotlight

Add Your Heading Text Here